Accreditation The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: The American Medical Directors Association designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AMDCP Credit Designation: This session has been approved for a total of 1.5 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
Session Description: The science of pharmacogenomics has made significant progress in the past decade since the mapping of The Human Genome, and many of these biomarkers and genetic tests have now been included on FDA-approved drug labeling. Moreover, significant inter-individual variability exists in antidepressant and antipsychotic response and prolongs time to response and remission which causes increased suffering and is associated with increased morbidity and mortality. Improving treatment using a more biologically informed selection of pharmacologic agents through genotyping has become a reality in clinical psychiatric practice. This session will also present the current literature addressing drug therapy for other select therapeutic areas highlighting the applicability of pharmacogenomics. Ethical, social, legal, and economic challenges of translating pharmacogenomics into clinical practice will be discussed. What should the prescriber/healthcare professional know about this emerging science and its implication for geriatric medicine?
Speakers(s): Amita R. Patel, MD, CMD; Joel Winner, MD; Manju T. Beier, PharmD
Disclosure(s): Amita R. Patel, MD, CMD - Lilly, BMS, Pfizer, Novartis, Astrazeneca: Speakers' Bureau Joel Winner, MD - AssureRx: Medical Director Manju T. Beier, PharmD has no financial disclosures to report.